Simple and accurate approaches to predict the activity of benzothiadiazine derivatives as HCV inhibitors

Medicinal Chemistry Research

Volumn 21, Issue 8, 2012, Pages 2079-2096

  Su, Li ^a   Li, Lina ^a   Li, Yanwei ^a   Zhang, Xiaoyun ^a   Huang, Xiaoyan ^a   Zhai, Honglin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

BMLR; HCV; QSAR; RBFNN; SVM

Indexed keywords

ANTIVIRUS AGENT; BENZOTHIADIAZINE DERIVATIVE;

ARTICLE; HEPATITIS C VIRUS; IC 50; MULTIPLE LINEAR REGRESSION ANALYSIS; NONHUMAN; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RADIAL BASED FUNCTION; SUPPORT VECTOR MACHINE; VIRUS INHIBITION;

EID: 84866057479     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9734-x     Document Type: Article

References (40)

1. Afantitis A, Melagraki G, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-Markopoulou O (2006) A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis. Mol Divers 10:405-414
2. Beaulieu PL, Bos M, Bousquet Y, Fazal G, Gauthier J, Gillard J, Goulet S, LaPlante S, Poupart MA, Lefebvre S, McKercher G, Pellerin C, Austel V, Kukolj G (2004) Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorg Med Chem Lett 14:119-124
3. Bosse TD, Larson DP, Wagner R, Hutchinson DK, Rockway TW, Kati WM, Liu Y, Masse S, Middleton T, Mo H, Montgomery D, Jiang W, Koev G, Kempf DJ, Molla A (2008) Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorg Med Chem Lett 18:568-570
4. Cheng Z, Zhang Y, Zhang W (2010) QSAR studies of imidazopyridine derivatives as Et-PKG inhibitors using the PSO-SVM approach. Med Chem Res. doi:10.1007/s00044-009-9272-y
5. Cohen J (1999) Public health effort unwittingly spread HCV. Science 285:27
6. Davood A, Nematollahi A, Iman M, Shafiee A (2010) Computational studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent: QSAR and docking. Med Chem Res 19:58-70
7. Donner PL, Xie QH, Pratt JK, Maring CJ, Kati W, Jiang W, Liu Y, Koev G, Masse S, Montgomery D, Molla A, Kempf DJ (2008) Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1, NS5B RNA-dependent RNA polymerase. Bioorg Med Chem Lett 18:2735-2738
8. Du H, Wang J, Watzl J, Zhang X, Hu Z (2008) Prediction of inhibition of matrix metalloproteinase inhibitors based on the combination of projection pursuit regression and grid search method. Chemom Intell Lab Syst 93:160-166
9. Harper S, Pacini B, Avolio S, Di Filippo M, Migliaccio G, Laufer R, De Francesco R, Rowley M, Narjes F (2005) Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. J Med Chem 48:1314-1317
10. Hirashima S, Oka T, Ikegashira K, Noji S, Yamanaka H, Hara Y, Goto H, Mizojiri R, Niwa Y, Noguchi T, Ando I, Ikeda S, Hashimoto H (2007) Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities: benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moiety. Bioorg Med Chem Lett 17:3181-3186
11. Hutchinson DK, Rosenberg T, Klein LL, Bosse TD, Larson DP, He W, JiangWW,KatiWM,KohlbrennerWE,Liu Y,Masse SV,Middleton T, Molla A, Montgomery DA, Beno DWA, Stewart KD, Stoll VS, Kempf DJ (2008) Hepatitis CNS5B polymerase inhibitors: 4,4-dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives. Bioorg Med Chem Lett 18:3887-3890
12. HyperChem 7.5 (2000) HyperChem Release 7.5 for Windows. Hypercube, Inc., Waterloo
13. Ikegashira K, Oka T, Hirashima S, Noji S, Yamanaka H, Hara Y, Adachi T, Tsuruha JI, Doi S, Hase Y, Noguchi T, Ando I, Ogura N, Ikeda S, Hashimoto H (2006) Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors. J Med Chem 49:6950-6953
14. Ishida T, Suzuki T, Hirashima S, Mizutani K, Yoshida A, Ando I, Ikeda S, Adachi T, Hashimoto H (2006) Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole. Bioorg Med Chem Lett 16:1859-1863
15. ISIS Draw 2.5 (2002) MDL Information Systems. Inc
16. Katritzky AR, Lobanov VS, Karelson M (1994) CODESSA: Reference Manual. University of Florida, Gainesville
17. Katritzky AR, Dobchev DA, Fara DC, Karelson M (2005) QSAR studies on 1-henylbenzimidazoles as inhibitors of the plateletderived growth factor. Bioorg Med Chem 13:6598-6608
18. Katritzky AR, Pacureanu LM, Dobchev DA, Fara DC, Duchowicz PR, Karelson M (2006) QSAR modeling of the inhibition of glycogen synthase kinase-3. Bioorg Med Chem 14:4987-5002
19. Katritzky AR, Slavov SH, Dobchev DA, Karelson M (2007) QSPR modeling of UV absorption intensities. J Comput Aided Mol Des 21:371-377
20. Khan AKR, Sahu VK, Singh RK, Khan SA (2009) Comparative QSTR study of saturated alcohols based on topological, constitutional, geometrical, and getaway descriptors. Med Chem Res 18:770-781
21. Krueger AC, Madigan DL, Jiang WW, Kati WM, Liu DC, Liu Y, Maring CJ, Masse S, McDaniel KF, Middleton T, Mo HM, Molla A, Montgomery D, Pratt JK, Rockway TW, Zhang R, Kempf DJ (2006) Inhibitors of HCVNS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl- benzothiadiazine sulfamides. Bioorg Med Chem Lett 16:3367-3370
22. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-a, non-B-hepatitis. Science 244:362-364
23. Lei B, Li S, Xi L, Li J, Liu H, Yao X (2009) Novel approaches for retention time prediction of oligonucleotides in ion-air reversed-hase high-erformance liquid chromatography. J Chromatogr A 1216:4434-4439
24. Louise-May S, Yang WG, Nie XT, Liu DM, Deshpande MS, Phadke AS, Huang MJ, Agarwal A (2007) Discovery of novel dialkyl substituted thiophene inhibitors of HCV by in silico screening of the NS5B RdRp. Bioorg Med Chem Lett 17:3905-3909
25. LüWJ, Chen YL, Ma WP, Zhang XY, Luan F, Liu MC, Chen XG, Hu ZD (2008) QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network. Eur J Med Chem 43:569-576
26. Luan F, Zhang XY, Zhang HX, Zhang RS, Liu MC, Hu ZD, Fan BT (2006) QSPR study of permeability coefficients through lowdensity polyethylene based on radial basis function neural networks and the heuristic method. Comput Mater Sci 37:454-461
27. Maldonado AG, Doucet JP, Petitjean M, Fan BT (2006) Molecular similarity and diversity in chemoinformatics: from theory to applications. Mol Divers 10:39-79
28. Melagraki G, Afantitis A, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-Markopoulou O (2007) Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure. Bioorg Med Chem 15: 7237-7247
29. Ni ZJ, Wagman AS (2004) Progress and development of small molecule HCV antivirals. Curr Opin Drug Discov Dev 7:446-459
30. Patel PD, Patel MR, Kaushik-Basu N, Talele TT (2008) 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. J Chem Inf Model 48:42-55
31. Pratt JK, Donner P, McDaniel KF, Maring CJ, Kati WM, Mo HM, Middleton T, Liu YY, Ng T, Xie QH, Zhang R, Montgomery D, Molla A, Kempf DJ, Kohlbrenner W (2005) Inhibitors of HCVNS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines. Bioorg Med Chem Lett 15:1577-1582
32. Rockway TW, Zhang R, Liu D, Betebenner DA, McDaniel KF, Pratt JK, Beno D, Montgomery D, Jiang WW, Masse S, Kati WM, Middleton T, Molla A, Maring CJ, Kempf DJ (2006) Inhibitors of HCVNS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4- hydroxy-1, 8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring. Bioorg Med Chem Lett 16:3833-3838
33. Ryu K, Kim ND, Il Choi S, Han CK, Yoon JH, No KT, Kim KH, Seong BL (2009) Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. Bioorg Med Chem 17:2975-2982
34. Stankiewicz-Drogon A, Palchykovska LG, Kostina VG, Alexeeva IV, Shved AD, Boguszewska-Chachulska AM (2008) New acridone-4-carboxylic acid derivatives as potential inhibitors of Hepatitis C virus infection. Bioorg Med Chem 16:8846-8852
35. Stansfield I, Ercolani C, Mackay A, Conte I, Pompei M, Koch U, Gennari N, Giuliano C, Rowley M, Narjes F (2009) Tetracyclic indole inhibitors of hepatitis C virus NS5B-olymerase. Bioorg Med Chem Lett 19:627-632
36. Stewart JPP (1989) MOPAC 6.0, quantum chemistry program exchange, program 455. Indiana University, Bloomington
37. Thitinan S, McConville JT (2009) Interferon alpha delivery systems for the treatment of hepatitis C. Int J Pharm 369:121-135
38. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F (2008) Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 47:1128-1135
39. Xia BB, Ma WP, Zheng B, Zhang XY, Fan BT (2008) Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor. Eur J Med Chem 43:1489-1498
40. Zhao C, Zhang H, Luan F, Zhang R, Liu M, Hu Z, Fan B (2007) QSAR method for prediction of protein-eptide binding affinity: application to MHC class I molecule HLA-A*0201. J Mol Graph Model 26:246-254